1293.4000 -6.50 (-0.50%)
NSE Sep 10, 2025 15:31 PM
Volume: 108.5K
 

1293.40
-0.50%
ICICI Securities Limited
Thyrocare Technologies has reported an improvement in gross margin (+270bps YoY) in Q1FY24 led by a decline in low margin partnership business. The company has revamped incentive structure offered to franchisees and this should drive a strong 12-14% volume growth in this segment.
Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.
More from Thyrocare Technologies Ltd.
Recommended